Trial Profile
Ultrasonographic modification of liver steatosis and visceral fat induced by treatment with losartan and simvastatin in hypertensive normocholesterolemic obese patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Simvastatin (Primary) ; Amlodipine
- Indications Hypertension
- Focus Pharmacodynamics
- 27 May 2008 New trial record.